Effectiveness, safety of enteric-coated vs uncoated aspirin in patients with cardiovascular disease

JAMA Cardiology

2023-10-04

(Press-News.org) About The Study: In this post hoc secondary analysis of 10,678 participants with atherosclerotic cardiovascular disease from a randomized clinical trial, enteric-coated aspirin was not associated with significantly higher risk of heart attack, stroke, or death or with lower bleeding risk compared with uncoated aspirin, regardless of dose, although a reduction in bleeding with enteric-coated aspirin cannot be excluded. More research is needed to confirm whether enteric-coated aspirin formulations or newer formulations will improve outcomes in this population.

Authors: Mark B. Effron, M.D., of the University of Queensland-Ochsner Clinical School in New Orleans, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamacardio.2023.3364)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2023.3364?guestAccessKey=bb07ae80-e9a3-46a8-95a7-faff2ca16b5a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=100423

END

ELSE PRESS RELEASES FROM THIS DATE:

These robots helped understand how insects evolved two distinct strategies of flight

2023-10-04

Robots built by engineers at the University of California San Diego helped achieve a major breakthrough in understanding how insect flight evolved, described in the Oct. 4, 2023 issue of the journal Nature. The study is a result of a six-year long collaboration between roboticists at UC San Diego and biophysicists at the Georgia Institute of Technology. The findings focus on how the two different modes of flight evolved in insects. Most insects use their brains to activate their flight muscles each wingstroke, just like we activate the muscles in our legs ...

New research finds that ancient carbon in rocks releases as much carbon dioxide as the world's volcanoes

2023-10-04

Main points: New research has overturned the traditional view that natural rock weathering acts as a CO2 sink that removes CO2 from the atmosphere. Instead, this can also act as a large CO2 source, rivalling that of volcanoes. The results have important implications for modelling climate change scenarios but at the moment, CO2 release from rock weathering is not captured in climate modelling. Future work will focus on whether human activities may be increasing CO2 release from rock weathering, and how this could be managed. A new study led by the University of Oxford has overturned the view ...

New "Assembly Theory" unifies physics and biology to explain evolution and complexity

2023-10-04

An international team of researchers has developed a new theoretical framework that bridges physics and biology to provide a unified approach for understanding how complexity and evolution emerge in nature. This new work on "Assembly Theory," published today in Nature, represents a major advance in our fundamental comprehension of biological evolution and how it is governed by the physical laws of the universe. This research builds on the team's previous work developing Assembly Theory as an empirically validated approach to life detection, ...

Unlocking the secrets of neuronal function: a universal workflow

2023-10-04

Biophysically detailed neuronal models provide a unique window into the workings of individual neurons. They enable researchers to manipulate neuronal properties systematically and reversibly, something that is often impossible in real-world experiments. These in silico models have played a pivotal role in advancing our understanding of how neuronal morphology influences excitability and how specific ion currents contribute to cell function. Additionally, they have been instrumental in building neuronal circuits to simulate and study brain activity, offering ...

Munich neuroscientist receives around 1.5 million euros for research into ALS and FTD

2023-10-04

Dr. Qihui Zhou, a neuroscientist at DZNE’s Munich site, has been awarded a “Starting Grant” from the European Research Council (ERC) worth about 1.5 million euros to investigate disease mechanisms of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). With her studies, which will focus on the role of immune cells in the disease process and on the most common genetic forms of ALS and FTD, Zhou aims to pave the way for better treatments. ALS and FTD are devastating diseases characterized by loss of brain cells for which there ...

INSEAD launches world’s largest XR immersive learning library for management education and research

2023-10-04

First business school to launch comprehensive library of VR Learning Experiences to make management education more impactful and to advance management research VR Learning Experiences already used by 40+ professors and 13K+ learners at INSEAD and now available globally via the INSEAD XR Portal Professor Ithai Stern, Academic Director of the INSEAD Immersive Learning Initiative, wins 2023 Strategic Management Society Educational Impact Award for his contribution to quality and innovation of strategic management teaching Fontainebleau ...

Largest dataset of thousands of proteins marks landmark step for research into human health

2023-10-04

Today, [Wednesday 4 October] the scientific journal Nature1 published the results of the world’s largest and most comprehensive study on the effects of common genetic variation on proteins circulating in the blood and how these associations can contribute to disease. This unprecedented population-scale investigation of proteins, powered by turning biological samples into data from UK Biobank, will help scientists better understand how and why diseases develop, which could help drive the development of new diagnostics and treatments for a wide range of health conditions. To develop this unique and unparalleled dataset, researchers measured the abundance of nearly ...

Selective removal of aging cells opens new possibilities for treating age-related diseases

2023-10-04

A research team, led by Professor Ja Hyoung Ryu from the Department of Chemistry at UNIST, in collaboration with Professor Hyewon Chung from Konkuk University, has achieved a significant breakthrough in the treatment of age-related diseases. Their cutting-edge technology offers a promising new approach by selectively removing aging cells, without harming normal healthy cells. This groundbreaking development is poised to redefine the future of healthcare and usher in a new era of targeted therapeutic interventions. Aging cells, known as senescent cells, contribute to various inflammatory conditions and age-related ailments as humans age. To address this issue, the research team focused on ...

CHOP researchers find barriers to driver training and licensure, especially among low-income teens

2023-10-04

Philadelphia, October 2, 2023 – Researchers from the Center for Injury Research and Prevention (CIRP) at Children’s Hospital of Philadelphia (CHOP) and the Stuart Weitzman School of Design at the University of Pennsylvania have found that teenagers living in lower-income areas of the Columbus, Ohio metro area are up to four times less likely to complete driver training and obtain their driver’s license before age 18. Long travel times to driving schools also impacted enrollment in driver education, affecting those from both higher- and lower-income areas. The findings, originally published in the journals Accident Analysis and Prevention ...

Vulnerability found in immunotherapy-resistant triple-negative breast cancer

2023-10-04

Researchers at Vanderbilt-Ingram Cancer Center have discovered a druggable target on natural killer cells that could potentially trigger a therapeutic response in patients with immunotherapy-resistant, triple-negative breast cancer. Currently, only about 15% of early-stage, triple-negative breast cancer patients benefit from combining immunotherapy, drugs that target immune cells to attack the tumor, with chemotherapy. Identifying why most patients don’t respond is critical for personalizing treatment plans and minimizing therapy ...

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Effectiveness, safety of enteric-coated vs uncoated aspirin in patients with cardiovascular disease

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: